ACLARIS THERAPEUTICS INC has a total of 74 patent applications. It increased the IP activity by 38.0%. Its first patent ever was published in 2007. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are POLICHEM SA, EURO-CELTIQUE SA and DEZIMA PHARMA B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 19 | |
#2 | WIPO (World Intellectual Property Organization) | 10 | |
#3 | EPO (European Patent Office) | 9 | |
#4 | Australia | 5 | |
#5 | China | 5 | |
#6 | Canada | 4 | |
#7 | Republic of Korea | 4 | |
#8 | Singapore | 4 | |
#9 | Brazil | 3 | |
#10 | Mexico | 3 | |
#11 | Hungary | 2 | |
#12 | Israel | 2 | |
#13 | Japan | 1 | |
#14 | Philippines | 1 | |
#15 | Russian Federation | 1 | |
#16 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Shanler Stuart D | 32 |
#2 | Powala Christopher | 29 |
#3 | Phillips Christopher | 23 |
#4 | Beger Brian | 23 |
#5 | Greenaway Evans Charles Rodney | 23 |
#6 | Brown Marc Barry | 22 |
#7 | Jacobsen Eric Jon | 19 |
#8 | Blinn James Robert | 19 |
#9 | Lim Sian Tiong | 18 |
#10 | Anderson David Randolph | 18 |
Publication | Filing date | Title |
---|---|---|
WO2021022178A1 | Substituted sulfonamide pyrrolopyridines as jak inhibitors | |
WO2021022186A1 | Deuterated mk2 pathway inhibitors and methods of using the same | |
WO2020223728A1 | Substituted pyrrolopyridines as jak inhibitors | |
CA3109192A1 | Pyrrolopyrimidine itk inhibitors | |
KR20200083553A | Substituted pyrrolopyrimidine JAK inhibitors and methods of making and using the same | |
WO2019090143A1 | Pyrazolyl pyrrolo[2,3-b]pyrimidine-5-carboxylate analogs and methods of making the same | |
US2019060311A1 | Compositions and methods for treatment of vitiligo | |
US2018208594A1 | Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer | |
KR20190039575A | Methods and compositions for the treatment of warts | |
WO2017091681A1 | Selective kinase inhibitors | |
BR112016024630A2 | topical composition and applicator | |
CN108478579A | Pyridone-pyridinyl compounds and application thereof | |
EP2648516A1 | Substituted pyridinone-pyridinyl compounds | |
AU2007203283A1 | Acrochordon alleviation |